Prof. Dr. Gisbert Schneider

Prof. Dr.  Gisbert Schneider

Prof. Dr. Gisbert Schneider

Full Professor at the Department of Chemistry and Applied Biosciences

ETH Zürich

Inst. f. Pharmazeutische Wiss.

HCI H 411

Vladimir-Prelog-Weg 1-5/10

8093 Zürich

Switzerland

Additional information

Research area

Gisbert Schneider’s research activities focus on the development and application of adaptive intelligent systems for molecular design and drug discovery. Homepage: www.modlab.ethz.ch

Gisbert Schneider received a doctorate in biochemistry from the Freie Universität Berlin, Germany, in 1994, where he also studied medicine and computer science.

He then worked as a postdoctoral researcher at the Benjamin Franklin University Clinic, Berlin, the Massachusetts Institute of Technology in Cambridge, MA, the University of Stockholm, Sweden, and the Max-Planck-Institute of Biophysics in Frankfurt, Germany.

From 1997 to 2001 he worked as a scientific specialist in the Pharmaceuticals Division at Hoffmann – La Roche Ltd, Basel, Switzerland.

In 2000, he received the venia legendi for biochemistry and bioinformatics from the University of Freiburg, Germany.

From 2002 to 2009, Gisbert Schneider was a full professor at Goethe-University in Frankfurt, Germany (Beilstein Endowed Chair for Chem- and Bioinformatics).

Since 2010, he has been full professor of Computer-Assisted Drug Design at the Institute of Pharmaceutical Sciences in the Department of Chemistry and Applied Biosciences, ETH Zurich.

From 2018 to 2020 he served as Associate Vice President for ETH Global and as founding Director of the ETH RETHINK think-and-do tank.

In 2021, he became Director of the Singapore-ETH Center in Singapore.

He is a co-founder of Endogena Therapeutics Inc. and AlloCyte Pharmaceuticals AG, and inSili.com LLC, an ETH spin-off company.

Gisbert Schneider has received numerous awards internationally, including the Ernst Schering Prize, Gmelin-Beilstein Award, Herman Skolnik Award, Prous Institute - Overton and Meyer Award for New Technologies in Drug Discovery, and the Falling Walls Science Breakthrough of the Year Award. He is an Elected Fellow of the University of Tokyo and Honorary Adjunct Professor at Goethe-University.

Honours

Year Distinction
2022 Ernst Schering Prize
2022 Gmelin-Beilstein Award
2022 Highly Cited Researcher (Clarivate)
2021 Falling Walls Science Breakthrough of the Year
2021 Highly Cited Researcher (Clarivate)
2020 Prous Institute - Overton and Meyer Award for New Technologies in Drug Discovery
2018 Falling Walls Circle, Berlin, Germany
2018 Herman Skolnik Award of the American Chemical Society, USA
2015 Fellow of The University of Tokyo (honorary title), The University of Tokyo, Japan
2015 Tour Lecturer of the Molecular Graphics and Modelling Society, UK
2014 "Golden Owl" (teaching award), ETH Zurich
2014 "Highly Cited Researcher" (Thomson Reuters)
2010 Appointed Adjunct Professor (honorary title), Goethe University, Frankfurt, Germany
2008 Visiting professor at the Université Louis Pasteur, Strasbourg, France
2006 Professor of the Year in the category of sciences and medicine (national award), Germany
JavaScript has been disabled in your browser